ÂÜÀòÂÒÂ×

Stephen Craven is an experienced professional in the pharmaceutical process engineering field, currently serving as Director of the Large Molecule Business Unit at APC, where responsibilities include leading biologics functional initiatives and overseeing large molecule process development. With a PhD in Chemical Engineering from University College Dublin, Stephen's academic research focused on modeling and advanced process control of PAT-enabled bioprocesses. Previous experience includes an intern position at Pfizer, where Stephen supervised distillation operations and contributed to quality assurance processes. Stephen's educational background also includes a Bachelor of Engineering in Chemical Engineering from University College Dublin and secondary education at De La Salle College, Dundalk.